A three years’ experience of Arteriovenous Fistula (AVF) cases in a tertiary care hospital of East Java, Indonesia: a descriptive observational study

Main Article Content

Rafaela Andira Ledyastatin
Caesario Tri Prasetyo
Gold Sunday Palm Tampubolon
Dhihintia Jiwangga

Keywords

arteriovenous fistula, end-stage renal disease, hemodialysis access

Abstract

Introduction: The incidence of end-stage renal disease (ESRD) globally is 700 million people approximately. Patients with ESRD need vascular access for hemodialysis as renal replacement therapy (RRT). Among hemodialysis access, arteriovenous fistula is considered as the most preferred form of vascular access due to its characteristics. This study aimed to to present a descriptive characteristic of arteriovenous fistula creation cases in a tertiary care hospital with a specific view of demographic parameters, fistulas' sites, type of fistulas.


Methods: We conducted a descriptive study of single-center in the Department of Thoracic, Cardiac and Vascular Surgery of Dr. Soetomo Academic General Hospital Surabaya, collected data from January 1st, 2017 to December 31st, 2020. All patients who undergo arteriovenous fistula creation considered as a subject in this study. We retrieved the characteristics of the patients, the type of fistula, the site, surgical technique, and underlying disease from patients’ electronic medical data records.


Results: A total of 167 patients requiring long-term hemodialysis in our center. Females were dominantly in our study with 56.9% (95). Most of AVFs were created on the left arm. Radiocephalic type of AVF was the most common arteriovenous fistula type found in 111 subjects (66.5%). The highest postoperative successful rate was found in brachiocephalic type in 78.8%, followed by radiocephalic AVF type with 66.7%. The wrist region was favorable in subjects (43.1%).


Conclusions: Arteriovenous fistulas for hemodialysis are needed and in our center. Radiocephalic AVFs are the most common type. Further study to learn the different aspects of arteriovenous fistula cases is needed to fulfill queries in the local population.

Abstract 293 | pdf Downloads 299

References

1. Heerspink, H. J. L. et al. (2020) ‘Dapagliflozin in Patients with Chronic Kidney Disease’, New England Journal of Medicine, 383(15), pp. 1436–1446. doi: 10.1056/nejmoa2024816.
2. Kazemzadeh, G. H. et al. (2012) ‘Primary patency rate of native AV fistula: Long term follow up’, International Journal of Clinical and Experimental Medicine, 5(2), pp. 173–178.
3. Solomonson, M. D., Johnson, M. E. and Ilstrup, D. (1994) ‘Risk factors in patients having surgery to create an arteriovenous fistula’, Anesthesia and Analgesia, 79(4), pp. 694–700. doi: 10.1213/00000539-199410000-00013.
4. Vigneau, C. et al. (2017) ‘Ten-years trends in renal replacement therapy for end-stage renal disease in mainland France: Lessons from the French Renal Epidemiology and Information Network (REIN) registry’, Nephrologie et Therapeutique, 13(4), pp. 228–235. doi: 10.1016/j.nephro.2016.07.453.
5. Pokhrel, A. et al. (2019) ‘Prevalence of Cardiovascular Risk Factors among Chronic Kidney Disease Patients Undergoing Hemodialysis in a Tertiary Care Center, Kathmandu, Nepal’, Nepal Medical College Journal, 21(4), pp. 313–318. doi: 10.3126/nmcj.v21i4.27629.
6. Santoro, D. et al. (2014) ‘Vascular access for hemodialysis: Current perspectives’, International Journal of Nephrology and Renovascular Disease, 7, pp. 281–294. doi: 10.2147/IJNRD.S46643.
7. de Castro Rodrigues Ferreira, F. et al. (2017) ‘Infectious complications as the leading cause of death after kidney transplantation: analysis of more than 10,000 transplants from a single center’, Journal of Nephrology, 30(4), pp. 601–606. doi: 10.1007/s40620-017-0379-9.
8. Konner, K. et al. (2002) ‘Tailoring the initial vascular access for dialysis patients’, Kidney International, 62(1), pp. 329–338. doi: 10.1046/j.1523-1755.2002.00436.x.
9. Bylsma Bylsma, L. C. et al. (2017) ‘Arteriovenous Fistulae for Haemodialysis: A Systematic Review and Meta-analysis of Efficacy and Safety Outcomes’, European Journal of Vascular and Endovascular Surgery, 54(4), pp. 513–522. doi: 10.1016/j.ejvs.2017.06.024.
10. Chan, C., Ochoa, C. J. and Katz, S. G. (2018) ‘Prognostic Factors for Arteriovenous Fistula Maturation’, Annals of Vascular Surgery, 49, pp. 273–276. doi: 10.1016/j.avsg.2018.01.069.
11. Hara, Y. et al. (2018) ‘Influence of arteriovenous fistula on daily living behaviors involving the upper limbs in hemodialysis patients: A cross-sectional questionnaire study’, BMC Nephrology, 19(1), pp. 1–9. doi: 10.1186/s12882-018-1097-9.
12. Rezapour, M. and Khavaninzadeh, M. (2014) ‘Association between non-matured arterio-venus fistula and blood pressure in hemodialysis patients’, Medical Journal of the Islamic Republic of Iran, 28(1), pp. 1–9.
13. Yan, Y. et al. (2018) ‘A meta-analysis of the association between diabetic patients and AVF failure in dialysis’, Renal Failure, 40(1), pp. 379–383. doi: 10.1080/0886022X.2018.1456464.